A federal bankruptcy court this week approved the sale of 23andMe to TTAM Research Institute - a new company launched by ...

Scientists have for the first time sequenced the most complete and oldest ancient Egyptian genome ever found—unlocking new ...

But while experts now know a fair amount about ancient Egyptian life, they still understand very little about the ...

Anne Wojcicki regains control of 23andMe, the company she co-founded and led as CEO, through her nonprofit TTAM with a $305 million bid at a bankruptcy auction.

TTAM will acquire substantially all of 23andMe’s assets for $305 million, including its Personal Genome Service and Research Services business lines as well as telehealth subsidiary Lemonaid Health.

The acquisition includes 23andMe’s Personal Genome Service, Total Health, Research Services divisions, its Biobank, and associated infrastructure.

The acquisition includes 23andMe’s Personal Genome Service, Total Health, Research Services, Biobank, and infrastructure, with Regeneron pledging no disruption to consumer services.